[New bone density conservation agents for osteoporosis under research and development: Ibandronate].
Tanaka
Ikuko
I
Department of Laboratory Medicine, Fujita Health University School of Medicine.
Hashimoto
Junko
J
Oshima
Hisaji
H
D000284:Administration, Oral; D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000493:pharmacokinetics; D001842:Bone and Bones / Q000378:metabolism; D004164:Diphosphonates / Q000008:administration & dosage / Q000493:pharmacokinetics; D004304:Dosage Forms; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D015195:Drug Design; D006801:Humans; D000077557:Ibandronic Acid; D007275:Injections, Intravenous; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D016032:Randomized Controlled Trials as Topic; D012106:Research; D016103:Spinal Fractures / Q000209:etiology / Q000517:prevention & control*
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D004304:Dosage Forms; D000077557:Ibandronic Acid